Sio Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,100
Closed -$532K – 89
2026
Q1
$532K Hold
10,100
– – 0.08% 64
2025
Q4
$408K Hold
10,100
– – 0.06% 62
2025
Q3
$75.9K Hold
10,100
– – 0.02% 48
2025
Q2
$37.7K Buy
10,100
+100
+1% +$312 0.01% 49
2025
Q1
$27.6K Hold
10,000
– – 0.01% 52
2024
Q4
$55.4K Hold
10,000
– – 0.02% 49
2024
Q3
$83.4K Buy
+10,000
New +$82.3K 0.03% 37

Other funds holding TERN

Sio Capital Management's TERN Position: Q2 2026 in Review

Sio Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 10,100 shares — an estimated $532K sold.

Sio Capital Management first reported a position in TERN in Q3 2024 and held it in 7 quarters. The position peaked at $532K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Sio Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 10,100 Terns Pharmaceuticals shares in Q2 2026, an estimated $532K.
  • Sio Capital Management first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Sio Capital Management's Terns Pharmaceuticals position peaked at $532K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.